跳至主要内容
临床试验/CTRI/2015/12/006439
CTRI/2015/12/006439招募中4 期

Steroid Tapering Protocol in Adult nephrotic syndrome due to MCD- A Randomised Control Trial of 2 regimens - MCD

PGIMER0 个研究点目标入组 188 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
PGIMER
入组人数
188

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Nephrotic syndrome
  • 2. Biopsy proved minimal change disease

排除标准

  • 1. Hepatitis B, C or human immunodeficiency virus-I/II infection
  • 2. Prior use of steroids/ immunosuppressive medication for any indication.
  • 3. Persistent renal dysfunction even after remission of proteinuria
  • 4. Nephrotic syndrome requiring >8 weeks to achieve remission
  • 5. History of Diabetes mellitus (DM)
  • 6. Abnormal liver function tests
  • 7. Presence of active sediments in the urine defined as > 5 RBCs/ HPF in unspun urine
  • 8. Anti nuclear antibody positivity
  • 9. Drug induced MCD (Analgesic or omeprazole induced)

研究者

发起方
PGIMER

相似试验